Photo of Richard Pfenninger, Jr.

Richard Pfenninger, Jr.

Board Member

Richard Pfenniger, Jr. has served on has served on the Board of Directors at GeneDx (formerly Sema4) since May 2022.

Richard is an experienced executive with significant expertise in the life science, healthcare, and education fields.

During his career, Richard has been an executive officer at several companies, including CEO and President of Continucare Corporation, a provider of primary care physician and practice management services, where he also served as Chairman of the Board of Directors. Previously, he was the CEO and Vice Chairman of Whitman Education Group, Inc. Prior to joining Whitman, he served in several different roles at IVAX Corporation, including COO, Senior Vice President- Legal Affairs, and General Counsel. Before that, Richard was engaged in the private practice of law.

In addition to GeneDx, Richard currently serves as a member of the Board of Directors for Opko, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, Asensus Surgical, Inc. (NYSE: ASXC), a medical device company, and Cocrystal Pharmaceuticals, Inc. (NASDAQ: COCP), a clinical stage biotechnology company. He is also the Vice Chairman of the Board of Trustees and a member of the Executive Committee of the Phillip and Patricia Frost Museum of Science.

Richard previously served as a director of GP Strategies Corporation (NYSE: GPX), a corporate education and training company, BioCardia, Inc. (NASDAQ: BCDA), a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases, and Wright Investors’ Services Holdings, Inc. (OTC US: IWSH), an investment management and financial advisory firm.

Richard received a Juris Doctor degree from the University of Florida and a Bachelor of Business Administration degree from Florida Atlantic University.